A novel an agent for maintaining or promoting collagen productivity is provided with.

An agent for maintaining or promoting collagen productivity of cells, comprising a wavelength conversion substance as an active ingredient; a composition and a product comprising the agent for maintaining or promoting collagen productivity; and a method for maintaining or promoting collagen productivity by means thereof are provided with. The present invention can exhibit a desirable effect on skin by effectively making use of ultraviolet light to maintain or promoting collagen productivity in skin cells.

A composition comprising or consisting of L-theanine and one or more fructooligosaccharides, wherein the ratio of L-theanine to froctooligosaccharide(s) is of about 2:1 to 99:1. A composition in the form of a food or nutraceutical, and also in the form of a powder, granules, suspension, tablet, capsule, lozenge, bakery item, sweets, drink, beverage or oral preparation.

A composition comprising or consisting of L-theanine and one or more fructooligosaccharides, wherein the ratio of L-theanine to froctooligosaccharide(s) is of about 2:1 to 99:1. A composition in the form of a food or nutraceutical, and also in the form of a powder, granules, suspension, tablet, capsule, lozenge, bakery item, sweets, drink, beverage or oral preparation.

The present invention provides methods of maintaining or increasing mobility and/or vitality by administering a composition comprising one or more polar lipids, in addition to uses, compositions, and medicaments comprising one or more polar lipids to maintain or increase mobility and/or vitality.

The present invention provides methods of maintaining or increasing mobility and/or vitality by administering a composition comprising one or more polar lipids, in addition to uses, compositions, and medicaments comprising one or more polar lipids to maintain or increase mobility and/or vitality.

The present invention provides methods of maintaining or increasing mobility and/or vitality by administering a composition comprising one or more polar lipids, in addition to uses, compositions, and medicaments comprising one or more polar lipids to maintain or increase mobility and/or vitality.

The present invention provides formulations comprising: L-threonine; Glycine; L-phenylalanine; DL-phenylalanine; Glutamine; NAD; and Magnesium, for use in the treatment of different types of addictions, such as: psychotropic medications, illicit drugs, tobacco and alcohol including, for example, but not limited to, narcotics, benzodiazepines, marijuana, cocaine, methamphetamines, antidepressants, and antipsychotics. The formulations of the present invention promote a detoxification process which facilitates that the brain repairs the damage caused by the abuse of addictive substances.

The present invention provides formulations comprising: L-threonine; Glycine; L-phenylalanine; DL-phenylalanine; Glutamine; NAD; and Magnesium, for use in the treatment of different types of addictions, such as: psychotropic medications, illicit drugs, tobacco and alcohol including, for example, but not limited to, narcotics, benzodiazepines, marijuana, cocaine, methamphetamines, antidepressants, and antipsychotics. The formulations of the present invention promote a detoxification process which facilitates that the brain repairs the damage caused by the abuse of addictive substances.

The present invention relates to a colonic purgative composition and a preparation method therefor, and more specifically, to a colonic purgative composition comprising sodium picosulfate, potassium sulfate and magnesium sulfate, and a preparation method therefor.

The present invention relates to a colonic purgative composition and a preparation method therefor, and more specifically, to a colonic purgative composition comprising sodium picosulfate, potassium sulfate and magnesium sulfate, and a preparation method therefor.